What is being tested?
Metanephrine and normetanephrine are breakdown products (metabolites) of the catecholamines epinephrine (adrenaline) and norepinephrine. This test measures the amounts of metanephrine and normetanephrine that are released into the urine over a 24-hour period.
Catecholamines are produced by the adrenal glands (as hormones), small triangular organs located on top of each kidney, and by cells of the sympathetic nervous system (called neurotransmitter substances or neurotransmitters). The primary catecholamines are dopamine, epinephrine (adrenaline), and norepinephrine. Catecholamines are released in response to physical or emotional stress. They help transmit nerve impulses in the brain, increase glucose and fatty acid release for energy, dilate small air passages in the lungs called bronchioles, and dilate the pupils. Norepinephrine also constricts blood vessels, which increases blood pressure, and epinephrine increases heart rate and the rate at which the body uses energy (metabolism).
After completing their actions, the catecholamines are broken down to form inactive compounds. Epinephrine breaks down into metanephrine and vanillylmandelic acid (VMA), and norepinephrine becomes normetanephrine and VMA. Both the hormones and their metabolites are eliminated from the body in the urine.
Catecholamines and their breakdown products are normally present in the urine in small fluctuating amounts that increase appreciably during and shortly after a stressful situation.
However, rare tumors of the adrenal gland called pheochromocytomas and rare tumors outside the adrenal glands called paragangliomas can produce large amounts of catecholamines and their metabolites, resulting in greatly increased concentrations in both the blood and urine. (These syndromes are often grouped together and abbreviated as PPGL). This can cause persistent or episodic periods of hypertension, which may lead to severe headaches. Other symptoms include heart palpitations, sweating, nausea, anxiety, and tingling in the hands and feet.
Pheochromocytomas and paragangliomas are rare. While a few are cancerous, most are benign and do not spread beyond their original location. Left untreated, however, these tumors may continue to grow and the symptoms may worsen. Over time, the hypertension caused by the excess hormones may cause kidney damage, heart disease, and raise the risk of a stroke or heart attack.
Although they are rare, it is important to diagnose and treat these tumors because they cause a potentially curable form of hypertension. In most cases, the tumors can be surgically removed and/or treated to eliminate or significantly reduce the amount of catecholamines being produced and to reduce or eliminate associated symptoms and complications.
How is the sample collected for testing?
For the 24-hour urine collection, all urine should be saved for a 24-hour period. Empty the bladder completely without collecting. Then collect urine for 24 hours only – no more than 24 hours. It is important that the sample be refrigerated during this time.
Is any test preparation needed to ensure the quality of the sample?
Catecholamine levels, and by extension the levels of their metabolites, are affected by various drugs, foods and stresses. Preparation for the test is important to ensure that an appropriate sample is collected and for correct interpretation of results. Follow any instructions given by your health care practitioner or the collection site or laboratory.
- You should talk to your health care provider about prescription medications and over-the-counter drugs and supplements that you are taking. It may be necessary to discontinue medications for some time prior to the test.
- However, you should not stop taking any medications without consulting your healthcare provider. Your health practitioner will work with you to identify potentially interfering substances and drug treatments and to determine which of them can be safely interrupted and which must be continued for your well-being.
- You will also be instructed on what foods to avoid.
- Avoid emotional and physical stresses and vigorous exercise prior to and during sample collection as they can increase catecholamine release and therefore affect metanephrine levels.
Common Questions
Sources
Sources Used in Current Review
2019 Review performed by Stanley S. Levinson, PhD, DABCC.
(August 10, 2018) Blake, M. Medscape: pheochromocytoma. Available online at https://emedicine.medscape.com/article/124059. Accessed July 2019.
Samuels M, et al. Case 14-2010: A 54-year old women with dizziness and falls. N Engl J Med 362, 2010, pages 1815-23.
Loscalzo J, et al. Case 8-2018: A 55-year old woman with shock and labile blood pressure. N Engl J Med 378, 2018, pages 1043-1053.
Alzrek R, et al. Update of Pheochromocytoma Syndromes: Genetics, Biochemical Evaluation, and Imaging. Front Endocrinol (Lausanne). 2018; 9: 515. Available online at https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6277481/. Accessed July 2019.
Sources Used in Previous Reviews
Thomas, Clayton L., Editor (1997). Taber’s Cyclopedic Medical Dictionary. F.A. Davis Company, Philadelphia, PA [18th Edition].
Pagana, Kathleen D. & Pagana, Timothy J. (2001). Mosby’s Diagnostic and Laboratory Test Reference 5th Edition: Mosby, Inc., Saint Louis, MO.
Sawka, A., et. al. (2003 February). A Comparison of Biochemical Tests for Pheochromocytoma: Measurement of Fractionated Plasma Metanephrines Compared with the Combination of 24-Hour Urinary Metanephrines and Catecholamines. The Journal of Clinical Endocrinology & Metabolism Vol. 88, No. 2 553-558 [On-line journal]. Available online at https://jcem.endojournals.org/cgi/content/full/88/2/553.
Brose, M. Updated (2004 August 3, Updated). Pheochromocytoma. MedlinePlus Medical Encyclopedia [On-line information]. Available online at https://www.nlm.nih.gov/medlineplus/ency/article/000340.htm.
(© 2005). Metanephrines, Plasma. ARUP’s Guide to Clinical Laboratory Testing [On-line information]. Available online at https://www.aruplab.com/guides/clt/tests/clt_a76b.jsp#2461156.
(© 2005). Metanephrines, Urine. ARUP’s Guide to Clinical Laboratory Testing [On-line information]. Available online at https://www.aruplab.com/guides/clt/tests/clt_a77b.jsp#1141889.
(© 1995-2005). Pheochromocytoma. The Merck Manual of Diagnosis and Therapy, Section 2. Endocrine And Metabolic Disorders, Chapter 9. Adrenal Disorders [On-line information]. Available online at https://www.merck.com/mrkshared/mmanual/section2/chapter9/9d.jsp.
Vogin, G. Reviewed (2002). Plasma Metanephrines Best to Diagnose Pheochromocytoma. Medscape Medical News [On-line news article]. Available online at https://www.medscape.com/viewarticle/430266?src=search.
Schwartz, G. and Sheps, S. (2004 May 06). Hypertension. MedScape Today from ACP Medicine [On-line information]. Available online at https://www.medscape.com/viewarticle/474790?src=search.
(1998 May 27, Updated). Adrenal Medullary Hormones. Colorado State University, Hypertexts for Biological Sciences [On-line hypertextbook]. Available online at https://arbl.cvmbs.colostate.edu/hbooks/pathphys/endocrine/adrenal/medhormones.html.
Pagana, Kathleen D. & Pagana, Timothy J. (© 2007). Mosby’s Diagnostic and Laboratory Test Reference. 8th Edition: Mosby, Inc., Saint Louis, MO. Pp 987-990.
Clarke, W. and Dufour, D. R., Editors (2006). Contemporary Practice in Clinical Chemistry. AACC Press, Washington, DC. Pp 382-383.
Wu, A. (2006). Tietz Clinical Guide to Laboratory Tests, Fourth Edition. Saunders Elsevier, St. Louis, Missouri. Pp 724-731.
Pacak, K. et. al. (2007 March 21). Pheochromocytoma: Recommendations for Clinical Practice from the First International Symposium. Medscape from Nat Clin Pract Endocrinol Metab. 2007;3(2):92-102. [On-line information]. Available online at https://www.medscape.com/viewarticle/553428. Accessed on 9/29/08.
Sweeney, A. et. al. (2007 September 11, Updated). Pheochromocytoma. EMedicine [On-line information]. Available online at https://www.emedicine.com/med/TOPIC1816.HTM. Accessed on 9/29/08.
Vilar, L. (2008 June 17). Adrenal Incidentalomas: Diagnostic Evaluation and Long-Term Follow-up. Medscape from Endocr Pract. 2008;14(3):269-278 [On-line information]. Available online at https://www.medscape.com/viewarticle/574415. Accessed on 9/29/08.
(2007 December). Pheochromocytoma. UrologyHealth.org [On-line information]. Available online at https://urologyhealth.org/adult/index.cfm?cat=02&topic=114. Accessed on 9/29/08.
Grossman, A. (2007 November Reviewed). Pheochromocytoma. Merck Manual for Professionals [On-line information]. Available online at https://www.merck.com/mmpe/print/sec12/ch153/ch153h.html. Accessed on 9/29/08.
Pagana, K. D. & Pagana, T. J. (© 2011). Mosby’s Diagnostic and Laboratory Test Reference 10th Edition: Mosby, Inc., Saint Louis, MO. Pp 1023-1026.
(Reviewed 2011 January). Pheochromocytoma. American Urological Association AUA Foundation [On-line information]. Available online at https://www.urologyhealth.org/urology/index.cfm?article=14. Accessed December 2011.
(© 1995-2011). Test ID: METAR83005, Metanephrines, Fractionated, Random, Urine. Mayo Clinic Mayo Medical Laboratories [On-line information]. Available online at https://www.mayomedicallaboratories.com/test-catalog/Overview/83005. Accessed December 2011.
Blake, M. and Sweeney, A. (Updated 2011 October 19). Pheochromocytoma. Medscape Reference [On-line information]. Available online at https://emedicine.medscape.com/article/124059-overview. Accessed December 2011.
Frank, E. et. al. (Updated 2011 June). Pheochromocytoma. ARUP Consult [On-line information]. Available online at https://www.arupconsult.com/Topics/Pheochromocytoma.html?client_ID=LTD. Accessed December 2011.
Blake, M. and Sweeney, A. (2014 June 16, Updated). Pheochromocytoma. Medscape Drugs & Diseases [On-line information]. Available online at https://emedicine.medscape.com/article/124059-overview. Accessed on 4/25/15.
Vuguin, P. (2013 June 27 Updated). Pediatric Pheochromocytoma. Medscape Drugs & Diseases [On-line information]. Available online at https://emedicine.medscape.com/article/988683-overview. Accessed 04/25/15.
Baldwin, E. et. al. (2015 April, Updated). Pheochromocytoma. ARUP Consult [On-line information]. Available online at https://www.arupconsult.com/Topics/Pheochromocytoma.html?client_ID=LTD. Accessed 4/25/15.
(© 1995–2015). Metanephrines, Fractionated, 24 Hour, Urine. Mayo Clinic Mayo Medical Laboratories [On-line information]. Available online at https://www.mayomedicallaboratories.com/test-catalog/Overview/83006. Accessed 04/25/15.
(2015 April 10, Updated). Unusual Cancers of Childhood Treatment (PDQ®). National Cancer Institute [On-line information]. Available online at https://www.cancer.gov/cancertopics/pdq/treatment/unusual-cancers-childhood/Patient/page7. Accessed 04/25/15.
Pagana, K. D., Pagana, T. J., and Pagana, T. N. (© 2015). Mosby’s Diagnostic & Laboratory Test Reference 12th Edition: Mosby, Inc., Saint Louis, MO. Pp 973-976.
National Cancer Institute: PDQ® Pheochromocytoma and Paraganglioma Treatment. Bethesda, MD: National Cancer Institute. Date last modified 04/30/2015. Available online at https://www.cancer.gov/types/pheochromocytoma/hp/pheochromocytoma-treatment-pdq. Accessed 07/21/2105.
Lenders, J.W.M. et al. Guidelines on Pheochromocytoma and Paraganglioma. J Clin Endocrinol Metab, June 2014, 99(6): 1915-42.
Eisenhofer, G. and Peitzch, M. Laboratory Evaluation of Pheochromocytoma and Paraganglioma. Clinical Chemistry, 2014, 60(12) 1486–1499.